Director, Market Access

Baylor Genetics•,
•Remote

About The Position

The Director, Market Access will develop and execute strategic payer account plans to expand coverage, contracting, and reimbursement for Baylor Genetics testing, with priority emphasis on WGS-first policies. The role builds value-based partnerships with national and regional commercial health plans, Medicare Advantage organizations, Medicaid and Managed Medicaid plans, integrated delivery networks, and other risk-bearing entities. The Director leads payer negotiations and develops payer-specific value propositions connecting WGS-first testing with improved diagnostic yield, earlier clinical decisions, reduced serial testing and avoidable procedures, and lower total cost of care. In partnership with HEOR, Medical Affairs, Clinical Affairs, Product, Finance, Revenue Cycle, and Commercial teams, the role develops evidence strategies, economic analyses, real-world evidence, and payer-facing value materials. The Director also leads payer pilots and evidence-development partnerships, advances positive medical policies, and reduces reimbursement and administrative barriers. The position monitors payer policy, reimbursement, competitive, and regulatory trends; maintains account plans and forecasts in established business systems; and represents Baylor Genetics in payer reviews, industry forums, and executive discussions. Success is measured by growth in covered and contracted lives, positive coverage decisions, favorable reimbursement, evidence collaborations, reduced payer friction, achievement of business objectives, and accurate forecasting. The role is remote and requires approximately 40% domestic travel.

Requirements

  • Bachelor’s degree in Life Sciences, Business, Healthcare Administration, Public Health, Health Economics, or a related field.
  • 14+ years of progressive experience in market access, payer strategy, reimbursement, managed care contracting, HEOR, or molecular diagnostics.
  • Demonstrated success securing payer coverage, negotiating contracts, improving reimbursement, or building value-based payer partnerships.
  • Working knowledge of commercial, Medicare, Medicaid, and Managed Medicaid coverage and reimbursement pathways.
  • Ability to interpret and communicate clinical utility, health-economic, real-world evidence, budget-impact, and total-cost-of-care analyses to payer audiences.
  • Executive-level communication, negotiation, deductive storytelling, and cross-functional influence skills.
  • Ability and willingness to travel approximately 40% domestically.

Nice To Haves

  • MBA, MPH, MHA, MS, PharmD, PhD, or equivalent advanced degree.
  • Experience in genomics, molecular diagnostics, rare disease, oncology, reproductive genetics, women’s health, WGS, or WES.
  • Established relationships with national and regional health plans, payer medical directors, policy teams, and contracting leaders.
  • Experience designing or executing HEOR studies, budget-impact models, real-world evidence programs, value dossiers, or payer pilots.
  • Experience advancing WGS-first or comprehensive genomic testing coverage strategies.

Responsibilities

  • Develop and execute strategic payer account plans to expand coverage, contracting, and reimbursement for Baylor Genetics testing, emphasizing WGS-first policies.
  • Establish value-based partnerships with commercial health plans, Medicare Advantage organizations, Medicaid and Managed Medicaid plans, integrated delivery networks, and other risk-bearing entities.
  • Lead payer negotiations for coverage policies, fee schedules, network agreements, value-based arrangements, and administrative pathways.
  • Create payer-specific value propositions for WGS-first testing, including its potential effects on diagnostic yield, clinical decision-making, testing utilization, avoidable procedures, and total cost of care.
  • Partner with HEOR, Medical Affairs, Clinical Affairs, Product, Finance, Revenue Cycle, and Commercial teams to develop evidence strategies, economic analyses, real-world evidence, and payer-facing value materials.
  • Lead payer initiatives, pilots, and evidence-development partnerships with defined measures, milestones, and decision criteria.
  • Secure positive medical policies and reduce prior authorization, documentation, coding, and reimbursement barriers.
  • Monitor payer policy, reimbursement, competitive, and regulatory trends and translate insights into account strategies and executive recommendations.
  • Maintain account plans, opportunity forecasts, contracting milestones, risks, decisions, and next steps in established business systems.
  • Represent Baylor Genetics at payer medical-policy reviews, value-evidence meetings, industry forums, and cross-functional executive discussions.
  • Report on covered and contracted lives, reimbursement performance, pipeline progress, risks, and expected financial impact.
  • Travel approximately 40% domestically.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service